Following a three-day bench trial in the matter on June 5-7, 2017 and after having considered the entire record in the case and the applicable law, the Court, through Trial Opinion, entered by The Honorable Richard G. Andrews in Orexigen Therapeutics, Inc. v. Actavis Laboratories FL, Inc., Civil Action No. 15-451-RGA (D.Del. October 13,

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Vanda Pharmaceuticals Inc., et al. v. Roxane Laboratories, Inc., Civil Action No. 13-1973-GMS (D.Del., August 25, 2016) (consolidated), the Court, following a five-day bench trial and having considered the entire record in the case (including but not limited to the parties’ post-trial proposed

Following a four day bench trial in a consolidated ANDA action before The Honorable Gregory M. Sleet in Genzyme Corp., et al. v. Dr. Reddy’s Laboratories, Ltd., et al., Civil Action Nos. 13-1506 and 13-1508-GMS (D.Del., May 11, 2016), the Court issued its findings of fact and conclusions of law pursuant to Federal Rule

By Memorandum Opinion entered by The Honorable Leonard P. Stark in Fairchild Semiconductor Corp. v. Power Integrations, Inc., Civil Action No. 12-540-LPS (D.Del., May 4, 2015), the Court granted plaintiffs’ motion for summary judgment in part as to no invalidity of U.S. Patent Number 7,525,259 (“the ‘259 patent”) due to lack of enablement, lack

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Pfizer Inc., et al. v. Mylan Pharmaceuticals Inc., C.A. No. 10-528-GMS (D.Del., October 22, 2014), the Court, following a four day bench trial and after having considered the entire record in the case and the applicable law, concluded that none of the asserted

By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Abbvie Inc. v. Hospira, Inc., C.A. No. 11-648- GMS (D.Del., October 24, 2014), the Court, following a two day bench trial and after having considered the entire record in the case and the applicable law, concluded that (1) the asserted claims of the

By Memorandum Opinion entered by The Honorable Sue L. Robinson in Intermec Technologies Corp. v. Palm Inc., Civil Action No. 07-272-SLR (D.Del., September 15, 2011), the Court granted Defendant Palm Inc.’s (“Palm”) motion for summary judgment relating to its infringement counterclaims in part by finding no invalidity as to its U.S. Patent Nos. 6,665,803